Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

globenewswire.com
DNOW

DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

globenewswire.com
DNOW

Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026

globenewswire.com
ORKA

Bronstein, Gewirtz & Grossman LLC Urges Stellantis N.V. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
STLA

Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
MNDY

Bronstein, Gewirtz & Grossman LLC Urges Eos Energy Enterprises, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
EOSE

Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
IBRX

Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
COTY

Bronstein, Gewirtz & Grossman LLC Urges Alight, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
ALIT

Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026

globenewswire.com
ORKA
View all news →